Ramatercept

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRamatercept
Drug Alias Nameramaterceptum雷特西普瑞马西普HGT-4510RAP-031 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsSarcopeniaMuscular AtrophyMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAcceleron Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcceleron Pharma Inc
Active IndicationsN/A
Inactive IndicationsSarcopeniaMuscular AtrophyMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksKEGG